AVEO Oncology Presents TiNivo-2 And TIVO-3 Results At ESMO 2024
16 Sep 2024 //
PR NEWSWIRE
AVEO Oncology Announces Late-Breaking TiNivo-2 Oral Presentation at ESMO
03 Sep 2024 //
PR NEWSWIRE
Aveo`s Fotivda fail as combo in kidney cancer
19 Jul 2024 //
FIERCE PHARMA
LG Chem enters Chinese osteoarthritis treatment market
03 Jul 2024 //
INDIANPHARMAPOST
LG Chem, AVEO: LG`s First Anti-Cancer Compound Enters Phase 1
13 Jun 2024 //
PR NEWSWIRE
LG Chem Announces Initiation of Two Phase 2 Trials (ROUTE & SIGNAL) of LB54640
17 Oct 2023 //
BUSINESSWIRE
LG Chem Targets Sixfold Sales Growth in Battery to KRW 30 Trillion by 2030
15 May 2023 //
PR NEWSWIRE
Samyang Holdings Enters Partnership with LG Chem for the Development
20 Apr 2023 //
PR NEWSWIRE
LG Chem locks in $200M vaccine supply deal with UNICEF
16 Mar 2023 //
FIERCE PHARMA
LG Chem’s Acquisition AVEO Sets Sights On Being Top 20 Oncology Company
08 Mar 2023 //
BUSINESSWIRE
Innovent and LG Chem Announce Strategic Collaboration for Tigulixostat
14 Dec 2022 //
PRNEWSWIRE
Korean buyer jumps into M&A game with $566M bid for Aveo Oncology
19 Oct 2022 //
ENDPTS
LG Chem to Acquire AVEO Oncology for $15.00 Per Share in Cash
18 Oct 2022 //
PRESS RELEASE
LG Chem Enters Final Stage of Clinical Development for New Gout Drug
03 Aug 2022 //
BUSINESSWIRE
LG Chem Announces First Subject Enrolled in PI Trial of NASH New Drug
14 Jul 2022 //
BUSINESSWIRE
MaxCyte Signs Platform License with LG Chem for Allogeneic CAR-T Programs
12 Jul 2022 //
GLOBENEWSWIRE
LG Chem Renews License Triggering Payment to Avacta
30 Jun 2022 //
BUSINESSWIRE
US regulator grants additional ODD status to LG Chem’s new obesity drug
16 Jun 2022 //
KOREABIOMED
Hanmi, LG Chem, Yuhan race to develop new obesity drug
23 May 2022 //
KOREABIOMED
LG Chem’s US partner starts phase 1 WT-1 targeting cancer drug study
12 May 2022 //
KOREABIOMED
Avacta Group and LG Chem Partnership Achieves Pre-clinical Development Milestone
29 Sep 2021 //
BUSINESSWIRE
LG Chem Life Sciences Innovation Center Announce the 2021 Golden Ticket Winner
23 Aug 2021 //
BUSINESSWIRE
LG Chem Announces Topline Results of LC350189
01 Jul 2021 //
BUSINESSWIRE
LG Chem Life Sciences Announces First Participant Dosed in First-in-Human Study
22 Feb 2021 //
BUSINESSWIRE
LG Chem eyes biopharmaceutical unit as next growth driver
10 Feb 2021 //
KOREATIMES
LG Chem to Contribute to Global Polio Eradication with Eupolio™
07 Jan 2021 //
BUSINESSWIRE
LG Chem to Contribute to Global Polio Eradication with Eupolio™
07 Jan 2021 //
AFP
LG Chem Life Sciences & TransThera Announce FDA Clearance of IND for TT-01025
02 Dec 2020 //
CANOE
LG Chem Life Sciences and TransThera Biosciences IND for TT-01025
01 Dec 2020 //
BUSINESSWIRE
Avacta, LG Chem Life Sciences Expand Drug Development Agreement
27 Aug 2020 //
PHARMATECH
LG Chem Life Sciences and TransThera Biosciences Announce License Agreement
17 Aug 2020 //
BUSINESSWIRE
5 pharmaceuticals win nod for sustained-release neuropathic pain reliever
27 Mar 2019 //
KOREKBIOMED